Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. News
  7. Most relevant
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about LONZA GROUP AG
09:30aAlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
01/27Lonza to Manufacture HaemaLogiX's Myeloma Drug Candidate KappaMab
MT
01/27HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candi..
PR
01/27HaemaLogiX Pty. Ltd. and Lonza Collaborates to Manufacture Kappamab, A Multiple Myeloma..
CI
01/26GLOBAL MARKETS LIVE : Vodafone, Qualcomm, Microsoft, Tesla, Intel...
01/26Lonza Group Ltd. Appoints Marion Helmes as Independent Member of the Board of Directors..
CI
01/26MARKETSCREENER'S WORLD PRESS REVIEW : January 26, 2022
01/26Lonza Group to Seek Acquisitions
CI
01/26EUROPEAN MIDDAY BRIEFING - Stocks Charge Ahead as Fed Clarity Eyed
DJ
01/26Lonza Offers Rosy Outlook After Divisional Growth Leads 2021 Sales To Beat Market Expec..
MT
01/26Lonza Posts Higher 2021 Sales; Confirms Mid-Term Targets
DJ
01/26Lonza's full-year core EBITDA up 20.7% on vaccine demand
RE
01/26Lonza's FY21 Profit Triples After Strong Sales Growth in All Divisions
MT
01/26LONZA : Full-Year Alternative Performance Measures Report
PU
01/26LONZA : Full-Year Results Report
PU
01/26LONZA : Full-Year Results Presentation
PU
01/26Lonza Delivers Strong 2021 performance with 20% CER Sales Growth
EQ
01/26Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022
CI
01/26Lonza Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/26Lonza Group Ltd. Proposes Dividend for 2021
CI
01/26Lonza Group Ltd. Announces Board Changes
CI
01/25Lonza Gets US Injunction in Patent Infringement Case Against Adva Biotechnology
MT
01/25AlphaValue/Baader Europe Lowers Price Target on Lonza Group, Upgrades Recommendation to..
MT
01/25LONZA : Obtains Order Preventing Infringement of Its Patents Covering the Cocoon« Platform
PU
01/19LONZA : Drug Product Services Participates in the RealHOPE Project to Assess and Improve P..
PU
01/18Lonza Signs Biologics Development Deal With Forbion, BioGeneration Ventures
MT
01/18LONZA : Forbion, and BioGeneration Ventures Extend Collaboration to Add Development and Ma..
PU
01/18LONZA : Launches bYlok Technology for the Discovery and Design of Bispecific Antibodies
PU
01/06AlphaValue/Baader Europe Lowers Price Target on Lonza Group
MT
01/03AlphaValue/Baader Europe Lowers Price Target on Lonza Group
MT
2021AlphaValue/Baader Europe Lowers Price Target on Lonza Group
MT
2021Moderna could be ready to develop Omicron booster in weeks - CEO
RE
2021Lonza and Agilent Announce Strategic Collaboration to Integrate New Analytical Technolo..
AQ
2021LONZA : and Agilent Announce Strategic Collaboration to Integrate New Analytical Technolog..
PU
2021AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Sell Recommendati..
MT
2021Lonza, Doer Biologics Enter Research License Deal For Multi-Specific Biotherapeutic
MT
2021LONZA : Doer Biologics signs licensing agreement with Lonza to develop multi-specific biot..
PU
2021Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon? Platform for..
CI
2021Lonza Teams Up with Bioqube Ventures on Potential Biologics, Small Molecules Developmen..
MT
2021LONZA : and Bioqube Ventures Sign a Framework Agreement for the Future Development and Man..
PU
2021Oxford BioMedica, Lonza, Fujifilm Eye UK's Vaccine Manufacturing Innovation Center
MT
2021Lonza Agrees to Manufacture Bluejay's Lead Antibody Candidate For Chronic Hepatitis B V..
MT
2021GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...
AX
2021LONZA : and BlueJay Therapeutics Announce Manufacturing Agreement for its Antibody BJT-778..
PU
2021Lonza to Boost Microbial Development Lab Capabilities at Swiss Site
MT
2021LONZA : to Expand Microbial Development Laboratories
PU
2021Lonza JV Bacthera, Seres to Jointly Produce Potential Gut Infection Treatment
MT
2021Cepsa explores chemicals sale to fund clean energy push - sources
RE
2021AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Sell Recommendati..
MT
2021Lonza to Buy Service Unit of Exosomics
MT
2021Lonza Group to Purchase Specialized Manufacturing Plant From Codiak BioSciences
MT
2021Lonza to Acquire Service Unit in Italy, Manufacturing Facility in US
DJ
2021Lonza to Acquire Codiak BioSciences Exosome Manufacturing Plant
DJ
2021Lonza to Acquire Exosomics Service Unit to Expand Exosomes Service Offering
PU
2021Lonza Group Ltd agreed to acquire Service unit from Exosomics Siena S.p.A.
CI
2021LONZA : Berenberg Lifts Price Target on Lonza Group, Maintains Buy Recommendation
MT
2021LONZA : Deutsche Bank Lifts Price Target on Lonza Group, Maintains Buy Recommendation
MT
2021LONZA : Intron Health Lowers Price Target on Lonza Group, Maintains Hold Recommendation
MT
2021Lonza Group Ltd Provides Sales Guidance for the Year 2024
CI
2021EUROPEAN MIDDAY BRIEFING - Stocks Fall as -2-
DJ
2021LONZA : Revises Mid-Term Financial Targets on Strong Business Momentum
MT
2021LONZA : Focuses On Long-Term Expansion With New Strategic Targets For 2024
MT
2021Lonza Provides New 2024 Targets; Anticipates No Extraordinary Capital Return -- Update
DJ
2021LONZA : Updates Mid-Term Financial Targets On Anticipated Business Growth
MT
2021LONZA : updates mid-term guidance, sees no extraordinary payouts
RE
2021Lonza Provides New 2024 Targets for Margins, Sales
DJ
2021LONZA : to Expand Mammalian Development Capacity in Singapore
MT
2021LONZA : to Expand Development Services for Mammalian Products in Singapore
PU
2021LONZA : To Manufacture Allarity Therapeutics' Kidney Cancer Candidate Dovitinib
MT
2021LONZA : Stifel Lifts Price Target on Lonza Group, Maintains Hold Recommendation
MT
2021Allarity Therapeutics and Lonza Collaborates to Manufacture Dovitinib, a Renal Cell Car..
CI
2021LONZA : to Invest in Expanding Drug Product Development Network in Switzerland
MT
2021LONZA : Invests to Expand Drug Product Development and Manufacturing Services in Switzerla..
PU
2021LONZA : Triumvira Begins Human Trials for T-Cell Cancer Therapy
MT
2021Lonza and Triumvira Immunologics Announces First Patient with HER2-overexpressing Cance..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on LONZA GROUP AG
07/27/22